Effect of AMR101 (Ethyl Icosapentate) on Triglyceride (Tg) Levels in Patients on Statins With High Tg Levels (≥ 200 and < 500 mg/dL)

NCT01047501 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

702

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypertriglyceridemia

Interventions

DRUG: AMR101 (ethyl icosapentate) - 4 g/day
DRUG: AMR101 (ethyl icosapentate) - 2 g/day
DRUG: Placebo

Sponsor

Amarin Pharma Inc.